tiprankstipranks
VistaGen Therapeutics (VTGN)
NASDAQ:VTGN
US Market
VTGN
VistaGen Therapeutics
RESEARCH TOOLSreports
Want to see VTGN full AI Analyst Report?

VistaGen Therapeutics (VTGN) Revenue

1,152 Followers
StatisticsMarket CapRevenue

VistaGen Therapeutics Revenue

VistaGen Therapeutics had a revenue of 465.00K in the quarter ending Mar 31, 2026, with 53.47%. This bring the company's revenue in the last twelve months to 1.27M, Decreased 60.76%. In the fiscal year ending Mar 31, 2026, VistaGen Therapeutics had annual revenue of 1.27M with 161.11% growth.
Revenue (ttm)
1.27M
Revenue Growth
―
P/S Ratio
8.05
Revenue/Employee
$26,438
Employees
48
Market Cap
$10.21M

Revenue Chart

Revenue History
Fiscal End Date
Revenue
Change
Growth
Mar 31, 2026
1.27M783.00K+161.11%
Mar 31, 2025
486.00K-578.00K-54.32%
Mar 31, 2024
1.06M1.29M-568.72%
Mar 31, 2023
-227.00K-1.34M-120.47%
Mar 31, 2022
1.11M19.40K+1.78%
Mar 31, 2021
1.09M―+∞%
Mar 31, 2020
―――
Mar 31, 2019
―――
Mar 31, 2018
―-1.25M-100.00%
Mar 31, 2017
1.25M――